{"count": 1, "results": [{"_id": "29248384", "pmid": 29248384, "title": "Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.", "journal": "Clin Ther", "authors": ["Sung KC", "Oh YS", "Cha DH", "Hong SJ", "Won KH", "Yoo KD", "Rha SW", "Ahn YK", "Ahn JC", "Jang JY", "Hong TJ", "Cho SK", "Park SH", "Hyon MS", "Nam CW", "Chae IH", "Yoo BS", "Song JM", "Jeong JO", "Yoon YW", "Kim BS", "Yang TH", "Cho DK", "Kim SH", "Choi YJ", "Ahn JH", "Jeon DW", "Kim HS"], "date": "2018-01-01T00:00:00Z", "doi": "10.1016/j.clinthera.2017.11.006", "meta_date_publication": "2018 Jan", "meta_volume": "40", "meta_issue": "1", "meta_pages": "50-63.e3", "score": 50086.957, "text_hl": "IMPLICATION: TAH triple therapy was more effective than was @<m>CHEMICAL_telmisartan_amlodipine_combination</m> @CHEMICAL_MESH:C548840 @@@TA@@@ double therapy in reducing BP in these @SPECIES_9606 @@@patients@@@ in Korea with @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@essential hypertension@@@ that did not adequately respond to @<m>CHEMICAL_telmisartan_amlodipine_combination</m> @CHEMICAL_MESH:C548840 @@@TA@@@. ", "citations": {"NLM": "Sung KC, Oh YS, Cha DH, Hong SJ, Won KH, Yoo KD, Rha SW, Ahn YK, Ahn JC, Jang JY, Hong TJ, Cho SK, Park SH, Hyon MS, Nam CW, Chae IH, Yoo BS, Song JM, Jeong JO, Yoon YW, Kim BS, Yang TH, Cho DK, Kim SH, Choi YJ, Ahn JH, Jeon DW, Kim HS. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study. Clin Ther. 2018 Jan;40(1):50-63.e3. PMID: 29248384", "BibTeX": "@article{29248384, title={Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.}, author={Sung KC and Oh YS and Cha DH and Hong SJ and Won KH and Yoo KD and Rha SW and Ahn YK and Ahn JC and Jang JY and Hong TJ and Cho SK and Park SH and Hyon MS and Nam CW and Chae IH and Yoo BS and Song JM and Jeong JO and Yoon YW and Kim BS and Yang TH and Cho DK and Kim SH and Choi YJ and Ahn JH and Jeon DW and Kim HS}, journal={Clin Ther}, volume={40}, number={1}, pages={50-63.e3}}"}}]}